MedWatch

4-0 to the rivals: Coloplast has lost its own patent war

Two years ago, former Coloplast CEO Lars Rasmussen announced that his company sought compensation from competing companies for violation of Coloplast’s patent on a catheter. However, the Danish medtech group has lost all liability suits so far, and competitors criticize the company.

Foto: Niels Hougaard

Former CEO in Coloplast, Lars Rasmussen, was confident about the result, when his company filed patent infringement suits against competing firms in August 2017:

“We have competitors that have been on the market for years and unlawfully taken revenue and income from us,” he said to Ritzau Finans back then.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Patienter må vente længere på ny medicin

Siden Medicinrådet blev etableret i 2017, er patienternes ventetid på ny medicin blevet tre gange længere, konkluderer en analyse fra Lif, der vil have Medicinrådet til at droppe unødvendige vurderingsmetoder. Medicinrådet arbejder på at nedbringe sagsbehandlingstiderne.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier